Drug Type Colony-stimulating factors |
Synonyms ATT 01 |
Target |
Action modulators |
Mechanism CSF-2R modulators(Granulocyte-macrophage colony-stimulating factor receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | United States | 28 Apr 2025 |






